Aktieanalys

SciBase: Germany shines and financing sorted - Redeye

Redeye Publicerad: 11 May 2023 10:33

Redeye saw a Q1 report that was slightly weaker than expected but not a material deviation. The German market continues to develop well and is profitable. The US delayed Medicare fee schedule review affected sales negatively in the quarter, but this issue has now been resolved. We have made small adjustments to our estimates and left our fair value range and Base case unchanged. With the financing sorted, the focus is now on the company's performance in the coming quarter.

Länk till analysen i sin helhet: https://www.redeye.se/research/905785/scibase-germany-shines-and-financing-sorted?utm_source=finwire&utm_medium=RSS

Nyheter om Scibase

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!